A detailed history of Jane Street Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Jane Street Group, LLC holds 58,954 shares of NVS stock, worth $5.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,954
Previous 104,237 43.44%
Holding current value
$5.84 Million
Previous $11.1 Million 38.9%
% of portfolio
0.0%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$106.13 - $120.89 $4.81 Million - $5.47 Million
-45,283 Reduced 43.44%
58,954 $6.78 Million
Q2 2024

Aug 14, 2024

BUY
$92.57 - $107.37 $6.5 Million - $7.54 Million
70,185 Added 206.11%
104,237 $11.1 Million
Q1 2024

May 15, 2024

SELL
$95.27 - $108.47 $13.5 Million - $15.4 Million
-141,683 Reduced 80.62%
34,052 $3.29 Million
Q4 2023

Feb 14, 2024

SELL
$92.27 - $101.54 $96,422 - $106,109
-1,045 Reduced 0.59%
175,735 $17.7 Million
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $5.45 Million - $6.05 Million
57,567 Added 48.29%
176,780 $18 Million
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $12.2 Million - $13.9 Million
-132,353 Reduced 52.61%
119,213 $12 Million
Q1 2023

May 15, 2023

SELL
$80.03 - $92.81 $17.2 Million - $20 Million
-215,021 Reduced 46.08%
251,566 $23.1 Million
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $12.9 Million - $15.8 Million
170,466 Added 57.57%
466,587 $42.3 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $4.65 Million - $5.44 Million
-62,373 Reduced 17.4%
296,121 $22.5 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $4.65 Million - $5.44 Million
-62,373 Reduced 17.4%
296,121 $22.5 Million
Q2 2022

Aug 16, 2022

SELL
$80.52 - $93.75 $18.9 Million - $22 Million
-234,181 Reduced 39.51%
358,494 $30.3 Million
Q1 2022

May 17, 2022

BUY
$80.11 - $90.62 $21.1 Million - $23.9 Million
263,945 Added 80.29%
592,675 $52 Million
Q4 2021

Feb 15, 2022

BUY
$79.7 - $88.13 $14.3 Million - $15.8 Million
178,825 Added 119.29%
328,730 $28.8 Million
Q3 2021

Nov 16, 2021

SELL
$81.78 - $95.14 $2.63 Million - $3.06 Million
-32,175 Reduced 17.67%
149,905 $12.3 Million
Q2 2021

Aug 16, 2021

BUY
$85.24 - $94.15 $14.7 Million - $16.2 Million
172,030 Added 1711.74%
182,080 $16.6 Million
Q1 2021

May 18, 2021

SELL
$83.5 - $98.47 $10.1 Million - $11.9 Million
-121,065 Reduced 92.33%
10,050 $860,000
Q4 2020

Feb 17, 2021

SELL
$78.07 - $94.43 $4.99 Million - $6.04 Million
-63,948 Reduced 32.78%
131,115 $12.4 Million
Q3 2020

Nov 17, 2020

BUY
$82.14 - $91.0 $2.44 Million - $2.7 Million
29,660 Added 17.93%
195,063 $17 Million
Q2 2020

Aug 17, 2020

BUY
$80.93 - $91.1 $9.38 Million - $10.6 Million
115,888 Added 234.05%
165,403 $14.4 Million
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $811,432 - $1.14 Million
-11,482 Reduced 18.82%
49,515 $4.08 Million
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $7.28 Million - $8.23 Million
-86,308 Reduced 58.59%
60,997 $5.78 Million
Q3 2019

Nov 14, 2019

SELL
$85.54 - $94.26 $14.2 Million - $15.6 Million
-165,954 Reduced 52.98%
147,305 $12.8 Million
Q2 2019

Aug 15, 2019

BUY
$75.4 - $92.8 $19.3 Million - $23.8 Million
255,985 Added 446.95%
313,259 $28.6 Million
Q1 2019

May 16, 2019

SELL
$75.32 - $86.15 $4.15 Million - $4.75 Million
-55,143 Reduced 49.05%
57,274 $5.51 Million
Q4 2018

Feb 15, 2019

BUY
$73.66 - $82.02 $7.93 Million - $8.83 Million
107,671 Added 2268.67%
112,417 $9.65 Million
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $11.6 Million - $13.4 Million
-172,644 Reduced 97.32%
4,746 $409,000
Q2 2018

Aug 15, 2018

BUY
$64.91 - $73.36 $10.3 Million - $11.6 Million
158,197 Added 824.24%
177,390 $13.4 Million
Q1 2018

May 15, 2018

SELL
$70.39 - $84.15 $11.3 Million - $13.5 Million
-160,187 Reduced 89.3%
19,193 $1.55 Million
Q4 2017

Feb 15, 2018

BUY
$72.33 - $77.64 $26,111 - $28,028
361 Added 0.2%
179,380 $15.1 Million
Q3 2017

Nov 14, 2017

BUY
$74.14 - $77.27 $13.3 Million - $13.8 Million
179,019
179,019 $15.4 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.